The prevalence and outcomes of depression in older HIV-positive adults in Northern Tanzania: a longitudinal study.
The prevalence and outcomes of depression in older HIV-positive adults in Northern Tanzania: a longitudinal study.
复制标题
DOI:
10.1007/s13365-023-01140-4
复制
发表时间:
2023-08
影响因子:
3.2
通讯作者:
Paddick, Stella Maria
中科院分区:
文献类型:
--
作者:
Dua, Damneek;Stubbs, Oliver;Urasa, Sarah;Rogathe, Jane;Duijinmaijer, Ashanti;Howlett, William;Dekker, Marieke;Kisoli, Aloyce;Mukaetova-Ladinska, Elizabeta B.;Gray, William K.;Lewis, Thomas;Walker, Richard W.;Dotchin, Catherine L.;Lwezuala, Bingileki;Makupa, Philip C.;Paddick, Stella Maria
Studies of depression and its outcomes in older people living with HIV (PLWH) are currently lacking in sub-Saharan Africa. This study aims to investigate the prevalence of psychiatric disorders in PLWH aged ≥ 50 years in Tanzania focussing on prevalence and 2-year outcomes of depression. PLWH aged ≥ 50 were systematically recruited from an outpatient clinic and assessed using the Mini-International Neuropsychiatric Interview (MINI). Neurological and functional impairment was assessed at year 2 follow-up. At baseline, 253 PLWH were recruited (72.3% female, median age 57, 95.5% on cART). DSM-IV depression was highly prevalent (20.9%), whereas other DSM-IV psychiatric disorders were uncommon. At follow-up (n = 162), incident cases of DSM-IV depression decreased from14.2 to 11.1% (χ2: 2.48, p = 0.29); this decline was not significant. Baseline depression was associated with increased functional and neurological impairment. At follow-up, depression was associated with negative life events (p = 0.001), neurological impairment (p < 0.001), and increased functional impairment (p = 0.018), but not with HIV and sociodemographic factors. In this setting, depression appears highly prevalent and associated with poorer neurological and functional outcomes and negative life events. Depression may be a future intervention target. The online version contains supplementary material available at 10.1007/s13365-023-01140-4.
登录
查看更多内容
影响因子:
6.8
作者:
Bell JA;Kivimäki M;Bullmore ET;Steptoe A;MRC ImmunoPsychiatry Consortium;Carvalho LA
通讯作者:
Carvalho LA
影响因子:
1.7
作者:
Grov C;Golub SA;Parsons JT;Brennan M;Karpiak SE
通讯作者:
Karpiak SE
DOI:
10.4068/cmj.2015.51.1.8
发表时间:
2015-04
期刊:
Chonnam medical journal
影响因子:
--
作者:
Kang HJ;Kim SY;Bae KY;Kim SW;Shin IS;Yoon JS;Kim JM
通讯作者:
Kim JM
DOI:
10.7860/jcdr/2014/7725.4927
发表时间:
2014-10-01
期刊:
Journal of clinical and diagnostic research : JCDR
影响因子:
--
作者:
Bhatia, M S;Munjal, Sahil
通讯作者:
Munjal, Sahil
影响因子:
3.7
作者:
Bernard C;Dabis F;de Rekeneire N
通讯作者:
de Rekeneire N